Found: 5
Select item for more details and to access through your institution.
Garetosmab in Fibrodysplasia Ossificans Progressiva: Clinical Pharmacology Results from the Phase 2 LUMINA‐1 Trial.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 2, p. 264, doi. 10.1002/jcph.2344
- By:
- Publication type:
- Article
TGF-Beta Induces Activin A Production in Dermal Fibroblasts Derived from Patients with Fibrodysplasia Ossificans Progressiva.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2299, doi. 10.3390/ijms24032299
- By:
- Publication type:
- Article
Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives [Corrigendum].
- Published in:
- Orthopedic Research & Reviews, 2022, v. 14, p. 147, doi. 10.2147/ORR.S373122
- By:
- Publication type:
- Article
Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives.
- Published in:
- Orthopedic Research & Reviews, 2022, v. 14, p. 113, doi. 10.2147/ORR.S337491
- By:
- Publication type:
- Article
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.732728
- By:
- Publication type:
- Article